GLOBAL STEREOTACTIC RADIOSURGERY DEVICE MARKET

INTRODUCTION

Stereotactic radiosurgery (SRS) is a revolutionary technique in the field of radiation therapy that allows for precise and targeted treatment of tumors and other abnormalities in the body. One of the key tools used in SRS is a specialized device known as a stereotactic radiosurgery device.

This device combines advanced imaging technology with a highly focused radiation beam to deliver concentrated doses of radiation to specific areas of the body.The stereotactic radiosurgery device consists of several components working in harmony to ensure accurate and effective treatment.

The first component is the imaging system, which can include computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans. These imaging techniques allow for detailed visualization of the target area, helping physicians precisely locate the abnormality to be treated. Once the target area is identified, the device utilizes a highly focused radiation beam to deliver treatment.

This beam is generated by a linear accelerator, which produces high-energy X-rays or gamma rays. The beam can be adjusted to conform to the shape and size of the target, sparing surrounding healthy tissues from unnecessary radiation exposure.To ensure the utmost precision, the stereotactic radiosurgery device incorporates a sophisticated guidance system.

This system uses specialized software to create a three-dimensional map of the treatment area, allowing physicians to precisely calculate the position and intensity of the radiation beam. Some devices also employ real-time tracking systems that continuously monitor the patient's position during treatment, making adjustments as needed to maintain accuracy.

GLOBAL STEREOTACTIC RADIOSURGERY DEVICE MARKET SIZE AND FORECAST

The Global Stereotactic radiosurgery device market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

GammaTile Therapy is a revolutionary treatment option offered by GT Medical Technologies for patients diagnosed with brain tumors, specifically malignant gliomas. It is a type of radiation therapy that utilizes surgically implantable tiles containing Cesium-131, a powerful radiation source.

These tiles are placed in the tumor cavity during surgery to deliver targeted radiation directly to the tumor bed, while minimizing damage to surrounding healthy brain tissue. The Cesium-131 radiation emits short-range and highly localized radiation, ensuring effective tumor control while reducing the risk of radiation-related complications.

This innovative therapy offers improved outcomes and quality of life for patients with brain tumors.The CyberKnife® S7™ System is a cutting-edge medical device developed by Accuray Incorporated. It combines advanced robotics, image guidance, and real-time tumor tracking to deliver precise radiation therapy for cancer treatment.

The system's robotic arm allows for non-invasive treatment with sub-millimeter accuracy, delivering high doses of radiation directly to tumors while minimizing exposure to surrounding healthy tissues. The CyberKnife® S7™ System utilizes advanced imaging techniques to continuously monitor the tumor's position during treatment, ensuring optimal targeting.

It offers patients a non-surgical option with minimal side effects and shorter treatment durations, providing an innovative approach to cancer care.

COMPANY PROFILE

• Accuray Incorporated
• Elekta AB
• Varian Medical Systems Inc.
• Brainlab AG
• Medtronic PLC

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Stereotactic radiosurgery device are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Stereotactic radiosurgery device and key vendor selection criteria
3. Where is the Stereotactic radiosurgery device manufactured? What is the average margin per unit?
4. Market share of Global Stereotactic radiosurgery device market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Stereotactic radiosurgery device in-house
6. key predictions for next 5 years in Global Stereotactic radiosurgery device market
7. Average B-2-B Stereotactic radiosurgery device market price in all segments
8. Latest trends in Stereotactic radiosurgery device market, by every market segment
9. The market size (both volume and value) of the Stereotactic radiosurgery device market in 2023-2030 and every year in between?
10. Production breakup of Stereotactic radiosurgery device market, by suppliers and their OEM relationship